Interestingly, when comparing CD4+CD20+ and CD8+CD20+ T cells in patients with early MS, MT1-MMP and MT5-MMP expression and MFI were significantly higher on CD4+CD20+ T cells (all p<0.0001). Here, CD8A is linked to myeloid sarcoma.